204 related articles for article (PubMed ID: 30991795)
1. Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin.
Alexandraki KI; Tsoli M; Kyriakopoulos G; Angelousi A; Nikolopoulos G; Kolomodi D; Kaltsas GA
Minerva Endocrinol; 2019 Dec; 44(4):378-386. PubMed ID: 30991795
[TBL] [Abstract][Full Text] [Related]
2. Management of neuroendocrine tumors of unknown primary.
Alexandraki K; Angelousi A; Boutzios G; Kyriakopoulos G; Rontogianni D; Kaltsas G
Rev Endocr Metab Disord; 2017 Dec; 18(4):423-431. PubMed ID: 29199361
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
Saller JJ; Haider M; Al-Diffalha S; Coppola D
Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Approaches to Neuroendocrine Neoplasms of Unknown Primary Site.
Berner AM; Pipinikas C; Ryan A; Dibra H; Moghul I; Webster A; Luong TV; Thirlwell C
Neuroendocrinology; 2020; 110(7-8):563-573. PubMed ID: 31658461
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge.
Rossi RE; Corti F; Pusceddu S; Milione M; Coppa J; Masoni B; Oldani S; Sabella G; Cafaro P; Repici A
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685605
[TBL] [Abstract][Full Text] [Related]
7. Clinical Usefulness of
Rinzivillo M; Partelli S; Prosperi D; Capurso G; Pizzichini P; Iannicelli E; Merola E; Muffatti F; Scopinaro F; Schillaci O; Salgarello M; Falconi M; Delle Fave G; Panzuto F
Oncologist; 2018 Feb; 23(2):186-192. PubMed ID: 29118267
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
Catena L; Bichisao E; Milione M; Valente M; Platania M; Pusceddu S; Ducceschi M; Zilembo N; Formisano B; Bajetta E
Tumori; 2011; 97(5):564-7. PubMed ID: 22158484
[TBL] [Abstract][Full Text] [Related]
9. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?
Koo J; Dhall D
Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine Tumors].
Jantze A; Haller C; Delaloye R
Praxis (Bern 1994); 2016 Jan; 105(1):7-12; quiz 13-4. PubMed ID: 26732711
[No Abstract] [Full Text] [Related]
11. Management of peritoneal metastasis from neuroendocrine tumors.
Au JT; Levine J; Aytaman A; Weber T; Serafini F
J Surg Oncol; 2013 Nov; 108(6):385-6. PubMed ID: 24142576
[No Abstract] [Full Text] [Related]
12. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
13. The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors.
Furnari M; Buda A; Delconte G; Citterio D; Voiosu T; Ballardini G; Cavallaro F; Savarino E; Mazzaferro V; Meroni E
J Gastrointestin Liver Dis; 2017 Jun; 26(2):151-156. PubMed ID: 28617885
[TBL] [Abstract][Full Text] [Related]
14. Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
Lim KHJ; Raja H; D'Arienzo P; Barriuso J; McNamara MG; Hubner RA; Mansoor W; Valle JW; Lamarca A
Neuroendocrinology; 2020; 110(7-8):688-696. PubMed ID: 31639796
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
Kos-Kudła B; Blicharz-Dorniak J; Handkiewicz-Junak D; Jarząb B; Jarząb M; Kunikowska J; Kuśnierz K; Król R; Królicki L; Krzakowski M; Nasierowska-Guttmejer A; Nowakowska-Duława E; Patkowski W; Szawłowski AW; ;
Endokrynol Pol; 2013; 64(6):418-43. PubMed ID: 24431116
[TBL] [Abstract][Full Text] [Related]
16. [Gastroenteropancreatic neuroendocrine neoplasms: concepts and related issues].
Lai M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):5-9, 23. PubMed ID: 27045235
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
Bolanowski M; Bednarczuk T; Bobek-Billewicz B; Handkiewicz-Junak D; Jeziorski A; Nowakowska-Duława E; Steinhof-Radwańska K; Zajęcki W; Zemczak A; Kos-Kudła B; ;
Endokrynol Pol; 2013; 64(6):480-93. PubMed ID: 24431119
[TBL] [Abstract][Full Text] [Related]
18. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
19. What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
Choe J; Kim KW; Kim HJ; Kim DW; Kim KP; Hong SM; Ryu JS; Tirumani SH; Krajewski K; Ramaiya N
Korean J Radiol; 2019 Jan; 20(1):5-17. PubMed ID: 30627018
[TBL] [Abstract][Full Text] [Related]
20. Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours.
Frilling A; Smith G; Clift AK; Martin J
Dig Liver Dis; 2014 Nov; 46(11):1038-42. PubMed ID: 25086997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
